City of Hope

There's no sweeter sound than a patient ringing the survivor bell. With his family by his side, Corona Fire Battalion Chief Brandon Willson recently rang the City of Hope Orange County survivor bell to celebrate his last round of chemotherapy. Brandon, from all of us at City of Hope, your strength fills our hearts with hope and inspiration.

Vote for City of Hope! Help us host a meaningful panel at SXSW to discuss, "The Right to Survive: Advocating for Equitable Cancer Care." City of Hope's panel will be hosted by Harlan Levine, M.D., president of health innovation and policy, in collaboration with Gary Puckrein, Ph.D., president and CEO of the National Minority Quality Forum, and patient advocate Kommah McDowell. From this discussion, we will talk about the unique challenges in cancer care and health inequity, understand how health care stakeholders can work together with cancer patients, and share solutions to expand access to lifesaving cancer care for every patient. Vote today: https://lnkd.in/ekS3iCBz

We’re proud to share that City of Hope has achieved accreditation from the American Nurses Credentialing Center and the Practice Transition Accreditation Program for our Nurse Fellowship Program (NFP). “This is an incredible accomplishment and the result of a focused collaborative effort across the system to provide innovative and contemporary education, tools and resources to our nurses so they can fulfill their own professional goals and transition to their new chosen specialty of oncology nursing,” said Chris Tarver, DNP, RN, CNS, NEA-BC, program director for the NFP. “To be accredited after only two years is [also] truly extraordinary." Congratulations to our nursing team on these significant achievements!

As City of Hope's new chief operating officer, Angelique Richard, Ph.D., R.N. oversees alignment and innovation across operations at City of Hope National Medical Center, City of Hope Los Angeles, City of Hope Orange County and the cancer center's clinical network in Southern California.   In a new interview with Becker's Healthcare, Dr. Richard talks about leadership, overcoming operational challenges and what’s on the horizon for City of Hope. Read more: https://bit.ly/3SItH9Z

City of Hope and IFLI - Institute for Follicular Lymphoma Innovation announced a $2 million, three-year collaboration to study spontaneous remission in follicular lymphoma, the most common, slow-growing non-Hodgkin's lymphoma. The collaboration aims to understand the tumor microenvironment in patients whose follicular lymphoma goes into remission without any treatment while being monitored over time. Raju K. Pillai, M.D., City of Hope associate clinical professor, Department of Pathology, and director, Pathology Core Laboratories, and Steven T. Rosen, M.D., executive vice president and director emeritus of City of Hope’s comprehensive cancer center and its Beckman Research Institute, professor, Department of Hematology & Hematopoietic Cell Transplantation, and Ted Schwartz Family Distinguished Chair in Hematologic Malignancies, will lead the research. Learn more: https://bit.ly/46yBpcH

Michelle Johann, D.N.P., R.N., loves coming to work every day. As a dedicated clinical practice education specialist and 25-year City of Hope employee, she takes every opportunity to make each patient feel at ease and cherished. During the COVID-19 pandemic, she led the Hope Tours Program at City of Hope, which allowed patients and their families to tour the facilities and meet staff ahead of their scheduled surgeries. This year, Michelle received the Off the Chart award for nursing excellence by the Simms/Mann Institute & Foundation, exemplifying her commitment and profound compassion. “I want [patients] to know that this is your home. You are accepted. You are embraced. You are loved. And you are a priority.” Thank you, Michelle, for helping to create an environment where each patient feels appreciated and valued. Read more about Michelle's dedication and commitment to our patients at City of Hope: https://bit.ly/3Sp1NzO

In addition to being recognized as top 5 in the nation for cancer care, we’re proud to share City of Hope cancer centers across the country were rated “high performing” for cancer procedures and conditions measured by U.S. News & World Report. City of Hope’s campus in Los Angeles was rated as “high performing” for all six cancer procedures and conditions tracked by U.S. News: - Lung cancer surgery - Colon cancer surgery - Prostate cancer surgery - Gynecologic cancer surgery - Gastroenterology and GI cancer surgery - The treatment of leukemia, lymphoma and myeloma. Additionally, City of Hope Atlanta was rated as “high performing” in colon cancer surgery, and City of Hope Chicago was rated as “high performing” in gynecologic cancer surgery. Learn more: https://bit.ly/3LqJshK #BestHospitals

Today, our CEO Robert Stone shared an Open Letter of Hope in The Wall Street Journal and Los Angeles Times highlighting our ranking as top 5 in the nation for cancer care by U.S. News & World Report and thanking our employees, patients, donors and other supporters who are helping make hope a reality for more people. Read the full letter: https://bit.ly/4fokBcq

Congratulations to Prajish Iyer, Ph.D., City of Hope staff scientist, on earning the prestigious Young Investigator Award from Chronic Lymphocytic Leukemia Society (CLL Society) for his research project, "Delineating the Role of Mitochondrial Dysregulation in Richter’s Transformation (RT)." The award recognizes early-career scientists committed to advancing the knowledge and treatment of CLL/SLL (small lymphocytic lymphoma). Dr. Iyer explains that although Richter’s Transformation (RT) is rare, it is a devastating event as most patients do not survive more than a year after diagnosis. “The goal of my research, supported by the CLL Society, is to understand the biological processes involved, with the hope that this research will pave the way for new treatment options to effectively target this aggressive form of cancer and bring hope to those battling RT." Dr. Iyer, bravo for your recognition! We admire your courage to study a rare and aggressive condition, your passion for research and making hope a reality for CLL and SLL patients. Read more: https://lnkd.in/eTuNEN4x

City of Hope's team is at the forefront of exciting therapeutic innovations for sarcoma. Three experts explain how sarcoma differs from other cancers, discuss clues that may indicate a person's risk for sarcoma and share advancements in sarcoma treatment. “This is a rare disease best handled by a specialized center,” shares Janet Yoon, M.D., clinical professor and medical director of the Pediatric Musculoskeletal Tumor Program at City of Hope Children’s Cancer Center. “You need an experienced, knowledgeable team. And we at City of Hope have such a team, along with researchers pushing the boundaries.” Read more: https://bit.ly/4f4zoZw